Literature DB >> 6489425

Effect of adrenaline on myocardial oxygen consumption during selective and non-selective beta-adrenoceptor blockade comparison of atenolol and pindolol.

H Ihlen, S Simonsen, D Welzel.   

Abstract

The effect of adrenaline on myocardial oxygen consumption (MVO2) during selective and non-selective beta-adrenoceptor blockade was examined in 26 patients with angina pectoris. Cardiac venous flow was measured by thermodilution and blood was sampled for metabolic studies. Thirteen patients were given atenolol 62.5 micrograms/kg i.v. and the other 13 patients pindolol 7.5 micrograms/kg i.v. Measurements were repeated before and during infusion of adrenaline 0.1 microgram/kg/min. Compared to the control situation, adrenaline increased MVO2 more in atenolol-treated (39%) than in pindolol-treated patients (11%). This was partly due to augmented external cardiac work. Arterial FFA was considerably increased in the atenolol group (105%), but was unchanged in the pindolol group, suggesting an additional metabolic mechanism. Thus, adrenaline stimulation, which is comparable to that found in acute myocardial infarction, increases MVO2 more during selective than non-selective beta-blockade.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489425

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  29 in total

Review 1.  Effects of drugs and hormones on lipolysis in heart.

Authors:  J J Lech; G J Jesmok; D N Calvert
Journal:  Fed Proc       Date:  1977-06

2.  Relationship between left ventricular and aortic dP-dt (max).

Authors:  S H Taylor; H M Snow; R J Linden
Journal:  Proc R Soc Med       Date:  1972-06

3.  Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise.

Authors:  I Brick; K J Hutchison; D G McDevitt; I C Roddie; R G Shanks
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

4.  Myocardial lipid and carbohydrate metabolism in healthy, fasting men at rest: studies during continuous infusion of 3 H-palmitate.

Authors:  B W Lassers; L Kaijser; L A Carlson
Journal:  Eur J Clin Invest       Date:  1972-08       Impact factor: 4.686

Review 5.  Beta-adrenergic blockade for survivors of acute myocardial infarction.

Authors:  W H Frishman; C D Furberg; W T Friedewald
Journal:  N Engl J Med       Date:  1984-03-29       Impact factor: 91.245

6.  Beneficial effects of beta blockers: a class action or individual pharmacologic spectrum?

Authors:  D C Harrison
Journal:  Circulation       Date:  1983-06       Impact factor: 29.690

7.  Cardiac dose-response relationships of oral and intravenous pindolol.

Authors:  S G Carruthers
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

8.  Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality.

Authors:  R P Karlsberg; P E Cryer; R Roberts
Journal:  Am Heart J       Date:  1981-07       Impact factor: 4.749

9.  The effect of pindolol on myocardial blood flow, metabolism and function during rest and pacing in patients with coronary heart disease.

Authors:  W Kupper; C W Hamm; W Bleifeld
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

10.  Effect of cell size on lipolysis and antilipolytic action of insulin in human fat cells.

Authors:  B Jacobsson; U Smith
Journal:  J Lipid Res       Date:  1972-09       Impact factor: 5.922

View more
  2 in total

Review 1.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  Effects of atenolol and pindolol on the hypokalaemic and cardiovascular responses to adrenaline infusion.

Authors:  K Forfang; S Simonsen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.